Cochrane COVID-19 Study Register
NCT04332835

Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
  1. Population (0)
  1. Intervention (2)
  2. Convalescent plasma
  3. Hydroxychloroquine
  1. Comparison (2)
  2. Hydroxychloroquine
  1. Outcome (8)
  2. Viral load
  3. Clinical status
  4. Death
  5. Length of ICU Stay
  6. Immunoglobulin G antibody to SARS-CoV-2
  7. Admission to Intensive Care Unit
  8. Antibodies
  9. Mechanical ventilation

Convalescent Plasma for Patients With COVID-19: a Randomized, Open Label, Parallel, Controlled Clinical Study

Universidad del Rosario
First Published (first received 2020 Apr 3)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT04332835)
Trial registry record
No Results
The process is based on obtaining plasma from patients recovered from COVID-19 in Colombia, and through a donation of plasma from the recovered, the subsequent transfusion of this to patients infected with coronavirus disease (COVID-19). Our group has reviewed the scientific evidence regarding the application of convalescent plasma for emergency viral outbreaks and has recommended the following protocol